Acumen Pharmaceuticals, Inc. (ABOS)
NASDAQ: ABOS · Real-Time Price · USD
2.240
-0.070 (-3.03%)
Jun 25, 2026, 1:45 PM EDT - Market open
Acumen Pharmaceuticals Market Cap
Acumen Pharmaceuticals has a market cap or net worth of $161.79 million as of June 25, 2026. Its market cap has increased by 126.35% in one year.
Market Cap
161.79M
Enterprise Value
68.16M
1-Year Change
126.35%
Ranking
Category
Stock Price
$2.24
Market Cap Chart
Since the IPO on July 1, 2021, Acumen Pharmaceuticals's market cap has decreased from $618.43M to $161.79M, a decrease of -73.84%. That is a compound annual growth rate of -23.58%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 25, 2026 | 161.79M | 26.59% |
| Dec 31, 2025 | 127.81M | 23.68% |
| Dec 31, 2024 | 103.34M | -53.53% |
| Dec 29, 2023 | 222.38M | 0.62% |
| Dec 30, 2022 | 221.00M | -19.22% |
| Dec 31, 2021 | 273.58M | -55.76% |
| Jul 1, 2021 | 618.43M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Precision BioSciences | 182.68M |
| LENZ Therapeutics | 182.48M |
| Equillium | 180.83M |
| MediWound | 179.42M |
| OnKure Therapeutics | 179.36M |
| Milestone Pharmaceuticals | 178.23M |
| NovaBridge Biosciences | 176.94M |
| Protalix BioTherapeutics | 174.03M |